Chua Terence C, Wen Wei, Chen Xiaohua, Kochan Nicole, Slavin Melissa J, Trollor Julian N, Brodaty Henry, Sachdev Perminder S
School of Psychiatry, University of New South Wales, NSW, Australia.
Am J Geriatr Psychiatry. 2009 Jul;17(7):602-13. doi: 10.1097/JGP.0b013e3181a76e0b.
Mild cognitive impairment (MCI) is recognized as a predementia state, but its definition is inconsistent and only 20%-30% develop dementia after 2 years. Biomarkers may help identify individuals at greatest risk of progressive decline. The authors examine a novel neuroimaging technique, diffusion tensor imaging (DTI) as a potential biomarker of MCI.
Cross-sectional prospective study.
Subjects were recruited randomly using the electoral roll from two electorates in East Sydney, Australia.
A community-dwelling sample (N = 249) and age 70-90 years.
Screening to exclude dementia, comprehensive neuropsychiatric assessment, cognitive test battery, structural magnetic resonance imaging and DTI to obtain measures of fractional anisotropy (FA) and mean diffusivity (MD). MCI was diagnosed by standard criteria.
After controlling for age, sex, and years of education, the amnestic MCI (aMCI) group demonstrated microstructural pathology in the parahippocampal white matter, frontal white matter, splenium of corpus callosum, and posterior cingulate region. The nonamnestic MCI (naMCI) group demonstrated microstructural pathology in the frontal white matter, internal capsule, occipital white matter, and the posterior cingulate region. A binary logistic regression model showed that DTI of the left posterior cingulate was significant in identifying persons with aMCI to an accuracy of 85.1%. Receiver operating characteristics curve analysis yielded a sensitivity of 80% and specificity of 60.3% in distinguishing aMCI from naMCI and the normal comparison group.
DTI of the posterior cingulate region discriminates MCI from cognitively normal individuals with accuracy and has the potential to be used as a biomarker of MCI, in particular aMCI.
轻度认知障碍(MCI)被认为是一种痴呆前状态,但其定义并不一致,且仅有20%-30%的患者在2年后会发展为痴呆。生物标志物可能有助于识别出进展性衰退风险最高的个体。作者研究了一种新型神经成像技术——扩散张量成像(DTI),将其作为MCI的一种潜在生物标志物。
横断面前瞻性研究。
使用澳大利亚东悉尼两个选区的选民名册随机招募受试者。
一个年龄在70-90岁的社区居住样本(N = 249)。
进行筛查以排除痴呆,进行全面的神经精神评估、认知测试组合、结构磁共振成像和DTI,以获取分数各向异性(FA)和平均扩散率(MD)的测量值。MCI通过标准标准进行诊断。
在控制年龄、性别和受教育年限后,遗忘型MCI(aMCI)组在海马旁白质、额叶白质、胼胝体压部和后扣带回区域表现出微观结构病理学改变。非遗忘型MCI(naMCI)组在额叶白质、内囊、枕叶白质和后扣带回区域表现出微观结构病理学改变。二元逻辑回归模型显示,左后扣带回的DTI在识别aMCI患者方面具有显著意义,准确率为85.1%。受试者工作特征曲线分析在区分aMCI与naMCI以及正常对照组时,敏感性为80%,特异性为60.3%。
后扣带回区域的DTI能够准确地区分MCI与认知正常个体,并且有潜力用作MCI尤其是aMCI的生物标志物。